A case of new-onset refractory status epilepticus (NORSE) due to Herpes Simplex Virus-1 encephalitis
Öz
Anahtar Kelimeler
Destekleyen Kurum
Proje Numarası
Kaynakça
- 1. Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018; 59: 739–44.
- 2. Specchio N, Pietrafusa N. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Dev Med Child Neurol 2020;62(8):897-905.
- 3. Iizuka T, Kanazawa N, Kaneko J, et al. Cryptogenic NORSE: its distinctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm 2017; 4: e396.
- 4. Bradshaw MJ, Venkatesan A. Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management. Neurotherapeutics 2016;13(3):493-508.
- 5. Rabinstein AA. Herpes Virus Encephalitis in Adults: Current Knowledge and Old Myths. Neurol Clin 2017;35(4):695-705.
- 6. Riancho J, Delgado-Alvarado M, Sedano MJ, Polo JM, Berciano J. Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience. Neurol Sci 2013;34(10):1879-81.
- 7. Fotedar N, Dolbow J, Layfield M, Thyagaraj S, Zande J. Epileptic negative myoclonus in herpes simplex virus encephalitis. Epileptic Disord 2021. doi: 10.1684/epd.2021.1401.
- 8. Laohathai C, Weber DJ, Hayat G, Thomas FP. Chronic herpes simplex type-1 encephalitis with intractable epilepsy in an immunosuppressed patient. Infection 2016;44(1):121-5.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Olgu Sunumu
Yazarlar
Sevil Alkan
*
0000-0003-1944-2477
Türkiye
Taylan Önder
0000-0003-0684-4047
Türkiye
Anıl Akça
0000-0001-5029-9838
Türkiye
Alper Şener
0000-0003-2774-8601
Türkiye
Yayımlanma Tarihi
30 Eylül 2022
Gönderilme Tarihi
14 Mart 2022
Kabul Tarihi
8 Haziran 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 13 Sayı: 3